These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. HLA-A2-restricted cytotoxic T lymphocyte responses to multiple Plasmodium falciparum sporozoite surface protein 2 epitopes in sporozoite-immunized volunteers. Wizel B, Houghten R, Church P, Tine JA, Lanar DE, Gordon DM, Ballou WR, Sette A, Hoffman SL. J Immunol; 1995 Jul 15; 155(2):766-75. PubMed ID: 7541824 [Abstract] [Full Text] [Related]
4. Induction of murine cytotoxic T lymphocytes against Plasmodium falciparum sporozoite surface protein 2. Wizel B, Rogers WO, Houghten RA, Lanar DE, Tine JA, Hoffman SL. Eur J Immunol; 1994 Jul 15; 24(7):1487-95. PubMed ID: 7517870 [Abstract] [Full Text] [Related]
5. The antibody response to Plasmodium falciparum Merozoite Surface Protein 4: comparative assessment of specificity and growth inhibitory antibody activity to infection-acquired and immunization-induced epitopes. de Silva HD, Saleh S, Kovacevic S, Wang L, Black CG, Plebanski M, Coppel RL. Malar J; 2011 Sep 16; 10():266. PubMed ID: 21920045 [Abstract] [Full Text] [Related]
6. Characterization of Plasmodium falciparum sporozoite surface protein 2. Rogers WO, Malik A, Mellouk S, Nakamura K, Rogers MD, Szarfman A, Gordon DM, Nussler AK, Aikawa M, Hoffman SL. Proc Natl Acad Sci U S A; 1992 Oct 01; 89(19):9176-80. PubMed ID: 1409621 [Abstract] [Full Text] [Related]
7. Plasmodium falciparum synthetic LbL microparticle vaccine elicits protective neutralizing antibody and parasite-specific cellular immune responses. Powell TJ, Tang J, Derome ME, Mitchell RA, Jacobs A, Deng Y, Palath N, Cardenas E, Boyd JG, Nardin E. Vaccine; 2013 Apr 08; 31(15):1898-904. PubMed ID: 23481177 [Abstract] [Full Text] [Related]
8. Mechanisms of protective immune responses induced by the Plasmodium falciparum circumsporozoite protein-based, self-assembling protein nanoparticle vaccine. McCoy ME, Golden HE, Doll TA, Yang Y, Kaba SA, Zou X, Gerbasi VR, Burkhard P, Lanar DE. Malar J; 2013 Apr 22; 12():136. PubMed ID: 23607541 [Abstract] [Full Text] [Related]
9. A modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts. Birkett A, Lyons K, Schmidt A, Boyd D, Oliveira GA, Siddique A, Nussenzweig R, Calvo-Calle JM, Nardin E. Infect Immun; 2002 Dec 22; 70(12):6860-70. PubMed ID: 12438363 [Abstract] [Full Text] [Related]
10. IgG2 antibodies against a clinical grade Plasmodium falciparum CSP vaccine antigen associate with protection against transgenic sporozoite challenge in mice. Schwenk R, DeBot M, Porter M, Nikki J, Rein L, Spaccapelo R, Crisanti A, Wightman PD, Ockenhouse CF, Dutta S. PLoS One; 2014 Dec 22; 9(10):e111020. PubMed ID: 25343487 [Abstract] [Full Text] [Related]
11. CD4(+) T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte protein. Charoenvit Y, Majam VF, Corradin G, Sacci JB, Wang R, Doolan DL, Jones TR, Abot E, Patarroyo ME, Guzman F, Hoffman SL. Infect Immun; 1999 Nov 22; 67(11):5604-14. PubMed ID: 10531206 [Abstract] [Full Text] [Related]
12. Protective effects of combining monoclonal antibodies and vaccines against the Plasmodium falciparum circumsporozoite protein. Wang LT, Pereira LS, Kiyuka PK, Schön A, Kisalu NK, Vistein R, Dillon M, Bonilla BG, Molina-Cruz A, Barillas-Mury C, Tan J, Idris AH, Francica JR, Seder RA. PLoS Pathog; 2021 Dec 22; 17(12):e1010133. PubMed ID: 34871332 [Abstract] [Full Text] [Related]
13. A conserved peptide sequence of the Plasmodium falciparum circumsporozoite protein and antipeptide antibodies inhibit Plasmodium berghei sporozoite invasion of Hep-G2 cells and protect immunized mice against P. berghei sporozoite challenge. Chatterjee S, Wery M, Sharma P, Chauhan VS. Infect Immun; 1995 Nov 22; 63(11):4375-81. PubMed ID: 7591073 [Abstract] [Full Text] [Related]
14. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles. Lalitha PV, Biswas S, Pillai CR, Saxena RK. Vaccine; 2008 Aug 18; 26(35):4526-35. PubMed ID: 18590786 [Abstract] [Full Text] [Related]
15. Characterization of murine monoclonal antibodies against a repetitive synthetic peptide from the circumsporozoite protein of the human malaria parasite, Plasmodium falciparum. Del Giudice G, Tougne C, Renia L, Ponnudurai T, Corradin G, Pessi A, Verdini AS, Louis JA, Mazier D, Lambert PH. Mol Immunol; 1991 Sep 18; 28(9):1003-9. PubMed ID: 1922106 [Abstract] [Full Text] [Related]
16. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes. Wang R, Charoenvit Y, Corradin G, De La Vega P, Franke ED, Hoffman SL. J Immunol; 1996 Nov 01; 157(9):4061-7. PubMed ID: 8892640 [Abstract] [Full Text] [Related]
17. Linear and multiple antigen peptides containing defined T and B epitopes of the Plasmodium yoelii circumsporozoite protein: antibody-mediated protection and boosting by sporozoite infection. Marussig M, Rénia L, Motard A, Miltgen F, Pétour P, Chauhan V, Corradin G, Mazier D. Int Immunol; 1997 Dec 01; 9(12):1817-24. PubMed ID: 9466309 [Abstract] [Full Text] [Related]
18. Protective humoral immunity elicited by a needle-free malaria vaccine comprised of a chimeric Plasmodium falciparum circumsporozoite protein and a Toll-like receptor 5 agonist, flagellin. Carapau D, Mitchell R, Nacer A, Shaw A, Othoro C, Frevert U, Nardin E. Infect Immun; 2013 Dec 01; 81(12):4350-62. PubMed ID: 24042110 [Abstract] [Full Text] [Related]